Tenon Medical, Inc. (NASDAQ:TNON) Sees Large Drop in Short Interest

Posted by Francis Steltz on Aug 27th, 2026

Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) was the target of a significant drop in short interest in August. As of August 14th, there was short interest totaling 8,042 shares, a drop of 96.4% from the July 30th total of 223,450 shares. Based on an average daily trading volume, of 112,734 shares, the days-to-cover ratio is currently 0.1 days. Currently, 2.9% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Alliance Global Partners reiterated a “buy” rating on shares of Tenon Medical in a research report on Wednesday, May 13th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tenon Medical in a research note on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Check Out Our Latest Stock Report on Tenon Medical

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of TNON. DRW Securities LLC bought a new stake in Tenon Medical in the fourth quarter worth approximately $98,000. Geode Capital Management LLC grew its position in Tenon Medical by 34.6% during the fourth quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock worth $63,000 after buying an additional 17,137 shares in the last quarter. Finally, Jane Street Group LLC acquired a new stake in Tenon Medical during the first quarter worth $29,000. Hedge funds and other institutional investors own 22.74% of the company’s stock.

Tenon Medical Trading Down 5.9%

Shares of TNON opened at $4.90 on Thursday. Tenon Medical has a 1-year low of $4.38 and a 1-year high of $50.40. The business’s 50-day moving average price is $8.59 and its 200 day moving average price is $19.97. The stock has a market capitalization of $1.67 million, a P/E ratio of -0.11 and a beta of 1.39.

Tenon Medical (NASDAQ:TNON – Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($12.35) EPS for the quarter, missing the consensus estimate of ($8.40) by ($3.95). The firm had revenue of $1.28 million during the quarter, compared to analysts’ expectations of $1.54 million. Tenon Medical had a negative net margin of 257.85% and a negative return on equity of 907.60%.

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.